High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma

This study is currently recruiting participants.
Verified January 2014 by Milton S. Hershey Medical Center
Sponsor:
Information provided by (Responsible Party):
Joseph Drabick, Milton S. Hershey Medical Center
ClinicalTrials.gov Identifier:
NCT01124734
First received: March 4, 2010
Last updated: January 7, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)